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Abstract 
While almost all mycobacterial species are saprophytic environmental organisms, a few, 
such as Mycobacterium tuberculosis, have evolved to cause transmissible human infection. 
By analysing the recent emergence and spread of the environmental organism 
Mycobacterium abscessus through the global Cystic Fibrosis population, we have defined 
key, generalisable steps involved in the pathogenic evolution of mycobacteria. We show that 
epigenetic modifiers, acquired through horizontal gene transfer, cause saltational increases 
in pathogenic potential of specific environmental clones. Allopatric parallel evolution during 
chronic lung infection then promotes rapid increases in virulence, through mutations in a 
discrete gene network that enhance growth within macrophages but impair fomite survival. 
As a consequence, we observe constrained pathogenic evolution while person-to-person 
transmission remains indirect, but postulate accelerated pathogenic adaptation once direct 
transmission is possible, as observed for M. tuberculosis. Our findings indicate how key 
interventions, such as early treatment and cross-infection control, might restrict existing, and 
prevent new, emergent mycobacterial pathogens. 
One sentence summary:   




Mycobacterium abscessus, a rapidly growing multidrug-resistant species of nontuberculous 
mycobacteria (NTM), has recently emerged as a major threat to individuals with Cystic 
Fibrosis (CF) and other chronic lung conditions [1-5]. In CF, M. abscessus causes 
accelerated inflammatory lung damage [6], is frequently impossible to treat [2-4], and 
prevents safe lung transplantation [5, 7]. Infection rates are increasing globally [2-4], driven 
in part by indirect person-to-person transmission of M. abscessus [8-11], probably through 
the generation of long-lived infectious aerosols and via fomite spread [9].  
Currently over 70% of infections in CF patients are caused by genetically clustered (and thus 
transmitted) isolates, of which the majority are from three dominant circulating clones 
(DCCs) that have emerged within the past 50 years and have spread globally [9] (Figure 
1A). Clustered isolates are more virulent than non-clustered isolates (when tested in vitro 
and in vivo) and result in worse clinical outcomes [9], suggesting that they are evolving from 
environmental saprophytes into obligate lung pathogens (potentially in a similar way to the 
ancestral Mycobacterium tuberculosis over 6000 years ago [12-14]) and thus provide a 
unique opportunity to define the critical (and generalisable) steps involved in pathogenic 
evolution of mycobacteria. 
Horizontal gene transfer drives saltational evolution 
We initially sought to understand how the DCCs may have emerged. We first examined 
whether mutational variation (through single nucleotide polymorphisms; SNPs) might explain 
the enhanced fitness of DCCs. However, analysis of the ratio of non-synonymous to 
synonymous SNPs (dN/dS) failed to provide evidence for positive selection on protein-
coding genes, as the phylogenetic branches leading to the last common ancestors for each 
DCC demonstrated strong purifying selection (dN/dS < 1), at similar levels to that seen for 
non-DCC branches (Supplementary Figure 1).  
We therefore examined whether gene acquisition through horizontal transfer might explain 
the increased fitness of the DCCs. To accurately analyse the accessory genome, we 
generated a pangenome graph (Figure 1A), with nodes as clusters of orthologous genes 
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and two nodes linked by an edge if they are adjacent in any contig [15], and found that each 
DCC had acquired a functionally similar repertoire of accessory genes (Figure 1B; 
Supplementary Figure 2, Supplementary Table 1). We observed a significant enrichment 
of genes involved in transcriptional regulation or DNA modification in the DCCs compared to 
non DCC isolates (Fishers exact test p < 0.001), acquisition of which would be expected to 
lead to large phenotypic differences and thus saltational changes in evolutionary fitness.  
To explore this process experimentally, we focused on a putative DNA methyltransferase 
(DpnM; Figure 1B), that was acquired by DCC3, a clone of particular interest as it was 
responsible for several large outbreaks in CF centres in the UK [8] and US [9].  
Comparing wild-type and knockout strains, we found that dpnM was responsible for N6 -
adenine DNA methylation (with RGATCY as the dominant motif) and that a dpnM knock-out 
caused global changes in gene expression (Figure 1B). We identified 52 differentially 
expressed genes, many of which are implicated in mycobacterial stress responses, 
metabolic re-wiring, transcriptional regulation, and intracellular survival (Figure 1C; 
Supplementary Table 2) including: an efflux pump (mmpS1; MAB_2649), reported to 
enhance growth within macrophages [16]; a nitrite reductase (MAB_3521c), potentially 
contributing to nitric oxide tolerance [17]; and a 2’-N-acetyltransferase (MAB_4395), 
orthologs of which have been shown to inactivate aminoglycoside antibiotics [18] and 
promote macrophage infection [19].  
As predicted from these transcriptional changes, the DpnM knockout showed: impaired 
survival in primary human macrophages (Figure 1D), which could be functionally 
complemented by the wild type methylase (but not a mutant enzyme unable to bind S–
adenosyl methionine); reduced tolerance to nitric oxide (Figure 1E); and increased 
susceptibility to amikacin (Figure 1F). It is therefore likely that these phenotypes were 
enhanced on initial acquisition of dpnM by DCC3.  
Our results therefore indicate that horizontal gene transfer, particularly of global 
transcriptional regulators, can provide an important mechanism for creating large phenotypic 
 5 
variance in environmental M. abscessus isolates, and consequently enabling saltational 
evolution towards enhanced human infectivity. Importantly, we believe this process may be 
generalisable across mycobacterial species. Graphical pangenome analysis indicates that 
gene gain/loss events are associated with the pathogenic evolution of several virulent clones 
including: Cluster 1a within Mycobacterium avium [20]; Clone A within Mycobacterium 
canettii [21], and the monophyletic M. tuberculosis complex (MTBC) from an M. canettii-like 
ancestor (Supplementary Figures 2 & 3, Supplementary Table 3 & 4) 
Chronic lung infection leads to allopatric evolution 
We next examined whether ongoing adaptation of infecting M. abscessus clones could 
further promote pathogenicity. We leveraged longitudinal sample collections from 18 
chronically infected individuals (Supplementary Figure 4, Supplementary Table 5) to 
explore the development of, and fluctuations in, within-host population diversity, using deep 
sequencing of sweeps of colonies from each sputum to capture both consensus SNPs and 
minority variants.   
We developed, and then experimentally validated (Supplementary Figure 4), a new 
method (MV-trees) to reconstruct the evolutionary trajectories of individual M. abscessus 
subclones within each patient. We observed that many within-host variants co-occurred at 
near-identical frequencies over time, implying linkage on the same genetic background as a 
single haplotype (Figure 2A). We then inferred an ancestor-descendent relationship 
between related pairs of haplotypes if the first was consistently found at an equal or higher 
frequency than the second over time. The resultant directed graphs are acyclic, demonstrate 
conditional independence, and can therefore be pruned through transitive reduction to 
provide direct evolutionary relationships (Figure 2B), thus revealing both the phylogenetic 
history (Figure 2C) and temporal frequencies (Figure 2D) of subclones within an individual.  
In all but two of the patients, we found that the total number (gamma diversity) and the 
genetic divergence of subclones were linearly correlated with the duration of infection, 
suggesting a clock-like evolutionary process (Supplementary Figure 5). In two individuals 
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however, we observed much larger than expected subclone repertoires (and genetic 
differences) due to the acquisition of hypermutator phenotypes, suggesting that rapid and 
unpredictable expansions of within-host diversity can occur, potentially accelerating ongoing 
M. abscessus evolution. 
We assumed that hypermutation was driven (in Patient 13) by a premature stop codon in 
uracil DNA glycoylase (UDG), an enzyme responsible for removing mis-incorporated uracil 
from DNA, and (in Patient 14) by a frameshift mutation in Nth endonuclease III, an enzyme 
that repairs damaged cytosines [9] (Supplementary Figure 6). 
When we explored the temporal changes in subclone frequencies in individuals, we found 
rapid fluctuations in apparent population composition over time (Figure 2D) and a greater 
difference in subclone repertoire between (beta diversity) than within (alpha diversity) 
sputum samples (Figure 2E), suggesting selective sampling (by each collected sputum) of a 
small subset of multiple infecting populations from presumably distinct anatomical areas of 
the lung.  
Using density-based clustering, we found that there were repeated patterns in the subclone 
repertoire present in individual sputa, not explicable by the timing of sample collection 
(Supplementary Figure 7), and indicating the presence (in 17 of 18 patients studied) of 
multiple discrete communities of subclones (Figure 2F). These communities were 
genetically closely related (Supplementary Figure 8) and most likely represent the outcome 
of distinct, spatially segregated (allopatric) adaptive evolution, made possible by lobar 
anatomy of the lung. By examining each community separately, we were able to capture the 
temporal dynamics in subclone frequencies within their specific niche (Figure 2G, H).  
Convergent evolution of M. abscessus within and between infected individuals  
As expected from allopatric evolution, we saw frequent examples of non-synonymous 
mutations occurring in the same gene in independent lineages within individuals (Figure 
3A). Of the 18 patients with reconstructed subclone histories, we detected within-host 
parallel evolution in 13 individuals, with 30 different genes accumulating more non-
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synonymous SNPs than would be expected by chance. Eight loci were found repeatedly 
mutated in multiple patients (suggesting critical host adaptations), comprising genes 
associated with smooth-to-rough morphotype transition (GPL locus), macrolide resistance 
(23S rRNA), cell wall biosynthesis (ubiA), and global regulation (phoR, crp/fnr, engA, a tetR 
family member, and ideR; Figure 3B).  
As an orthogonal approach, we also identified genes accumulating an excess of non-
synonymous consensus SNPs during M. abscessus infection, by examining isolates from 
201 CF patients with longitudinal samples [9] (Figure 3C). Many of the genes identified by 
these within- and between-patient analyses form part of a single functional network (Figure 
3D) and are implicated in the control of macrophage invasion by mycobacteria [22-26].  
Five genes (phoR, ubiA, ideR, engA and crp/fnr) are likely to be under very strong 
evolutionary pressure, since they were identified in both analyses, and appear to be 
specifically important for lung adaptation. Examining genomic data from laparoscopy-
associated M. abscessus wound infections [27], we found that non-synonymous mutations in 
these genes occurred at significantly lower rates than we observe during pulmonary disease 
(c2 test: p = 0.02).  
To explore the functional impact of deleterious mutations in these genes, we created 
isogenic inducible knockdown mutants (using a modified CRISPR-dCas9 system, 
Supplementary Methods) and screened them for phenotypic differences during 
macrophage infection. We found that all five gene hypomorphs were both less readily 
phagocytosed and showed enhanced intracellular survival (Figure 3E), implying that within-
host evolutionary pressures may be focused on avoiding macrophage killing. 
We found that mutations in these genes were non-randomly distributed, with significant 
enrichment in specific domains (Supplementary Figure 9), suggesting that the SNPs might 
be functionally equivalent. Most noticeably, within phoR, the most common gene to acquire 
non-synonymous mutations during lung infection, almost 70% of all within-host mutations 
occurred in the sensor loop (Supplementary Figure 9; Fisher’s exact test p < 0.001). PhoR, 
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a histidine kinase response regulator, is part of the PhoPR two-component system that in M. 
tuberculosis is required for macrophage survival and in vivo virulence [25]. 
Deletion of phoPR in M. abscessus, however, resulted in decreased macrophage uptake 
and increased intracellular survival (Figure 3F; Supplementary Figure 10), phenocopying 
the behaviour of the phoR hypomorph (Figure 3E), and suggesting a very different role for 
PhoPR in M. abscessus compared to M. tuberculosis. While we were able to complement 
the phenotype by merodiploid expression of wild type phoR, expression of the patient-
adapted phoR (containing a T140K sensor loop mutation) resulted in even greater 
intracellular survival (Figure 3F). 
Similarly, infection of bENaC-tg mice, which phenocopy CF lung disease [28], also revealed 
that the phoPR knockout mutant was more pathogenic than wild type M. abscessus and 
could be complemented by wildtype (but not patient-adapted) phoR (Figure 3G & H), 
confirming that the mutations acquired during lung infection in CF patients result in 
increased virulence through loss of protein function.  
Thus, our results indicate that within-host allopatric evolution drives pathogenic adaptation of 
specific lineages of M. abscessus and is influenced by the chronicity of infection, as well as 
presumably total bacterial community size, mutation rate, and the stringency of various 
selection pressures. The impact of these adaptive changes on lineage virulence will, 
however, depend on the presence of person-to-person transmission allowing multiple rounds 
of within-host evolution for that lineage. 
Indirect transmission constrains pathogenic evolution 
We therefore measured the transmissibility of the most frequently occurring adaptive 
mutations between patients (through analysis of a collection of clinical isolates of M. 
abscessus from 532 individuals with CF from around the World [9]), by determining the 
proportion of mutations that are unique to a single patient, or have been shared amongst 
multiple clustered patients.  
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We found that within-host adaptive mutations had impacts on transmission fitness that were 
variously mild (for example the 16S and 23S rRNA mutations causing aminoglycoside and 
macrolide antibiotic resistance); moderate (phoR sensor loop mutations); or severe (such as 
mutations in the GPL locus causing smooth-to-rough morphotype transitions), while non-
adaptive mutations, such as those in non-sensor regions of phoR, were transmitted freely 
(Figure 4A).  
Our findings imply that pathogenic evolution of M. abscessus may be constrained by the 
competing requirement to maintain transmission fitness, and suggest that long-term within-
patient maintenance of less host-adapted ancestral subclones (Supplementary Figure 10) 
may be important for successful spread to other patients.  
For example, while we could identify transmission of adaptive sensor-loop SNPs between 
some patients (Figure 4B), we also found instances where there appeared to be preferential 
cross-infection by subclones with un-evolved phoR, despite the parallel evolution of multiple 
adaptive phoR mutations in that individual (Figure 4C).  
Since we have previously shown that transmission of M. abscessus between CF patients is 
indirect [8], probably through the generation of long-lived infectious aerosols or via fomites 
[9], we wondered whether mutations that maximally increase virulence might concomitantly 
impair environmental survival, and thereby explain their transmission fitness cost. In support 
of this model, we found that both phoR knockout mutants and rough isolates with GPL 
mutations (which also show increased virulence in vitro and in vivo [26, 29]) demonstrate 
impaired survival on fomites compared to isogenic controls (Figure 4D), and represent a 
clear barrier to optimal pathogenic evolution. 
Discussion 
Our results point to what may be a generalisable model for mycobacterial pathogenic 
evolution (Supplementary Figure 12). Initially, horizontal gene acquisition (particularly of 
genes with global transcriptional effects) by environmental clones drives saltational evolution 
across fitness landscapes, increasing virulence of particular strains, and giving rise to the 
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ancestors of the dominant circulating clones of M. abscessus, as well as to virulent clones in 
other mycobacterial species including monophyletic MTBC (Supplementary Figure 2 & 3). 
We highlight the importance of changes in DNA modification, particularly methylation, in 
driving pathogenic evolution of clones, which has occurred through gene acquisition in M. 
abscessus and M. avium clones, and gene loss in M. canettii.  We note that lineage specific 
differences in DNA methylation have also been suggested to alter M. tuberculosis behaviour 
[30]. 
Next, allopatric within-host adaptation during chronic infection drives increased intracellular 
survival within macrophages and inflammatory lung damage. Pathogenic evolution is 
however constrained while transmission is via environmental intermediaries, since the most 
highly adapted strains lose transmission fitness through reduced fomite survival.  
Ultimately, we predict that opportunities for direct transmission of emergent mycobacteria 
(potentially through increases in population density and/or host susceptibility) will permit 
unconstrained, accelerated evolution into an obligate pathogen (accompanied by permanent 
loss of the smooth morphotype); as occurred in M. tuberculosis an estimated 4,000-6,000 
years ago [12].  
Our findings thus define the key steps involved in the evolution of mycobacteria but also 
have immediate implications for the clinical management of M. abscessus. They highlight: 
the importance of minimising within-host adaptation, potentially through immediate treatment 
of infected individuals rather than waiting (as international guidelines currently recommend 
[1,2,5]) for radiological and symptom changes; the necessity (given allopatric evolution 
within the lungs) of testing several colonies from multiple samples to define the behaviour 
and antibiotic resistance of infecting strains; and the critical need to prevent person-to-
person transmission (through enhanced infection control measures [31,32]) in order to block 
multiple rounds of pathogenic evolution.  
 
 11 
Material and methods 
Whole genome dataset 
We utilized a previously described (9) collection of whole genome data for 1173 clinical M. 
abscessus samples collected from 526 patients, obtained from UK CF clinics and their 
associated regional reference laboratories, as well as CF Centres in the US (UNC Chapel 
Hill), the Republic of Ireland (Dublin), mainland Europe (Denmark, Sweden, The Netherlands), 
and Australia (Queensland). All sequence data associated with this study is deposited in the 
European Nucleotide Archive under project accession ERP001039.  
Evolutionary analyses of DCCs 
Raw reads from a dataset consisting of one isolate per patient (n=526) were mapped to the 
M. a. abscessus ATCC19977(35) reference genome using BWA-MEM (v. 0.7.12)(36) using 
default parameters. Variants were called using Samtools (v.1.2.1) and Bcftools (v.1.2.1) (37). 
A maximum likelihood phylogenetic tree was inferred from these sites using RAxML 
(v.v.8.2.8)(38). In order to analyze the genetic changes occurring on the branches leading to 
the last common ancestors (LCA) of the DCCs, the SNPs were mapped back onto the 
phylogeny using the ACCTRAN parsimony algorithm (custom script written by Simon Harris). 
To identify whether a change in selection pressure had occurred on the branches leading to 
the LCA of each of the DCCs, which could be indicative of adaptation to a novel environment, 
the ratio of nonsynonymous SNPs per nonsynonymous site to synonymous SNPs per 
synonymous sites (dN/dS) was calculated for each branch of the phylogeny using the Nei-
Gojobori method(39).  
Pangenome analyses 
Datasets for pangenome analyses were obtained from previous publications for M. abscessus 
(40-44), M. avium (20), M. tuberculosis complex (45-58) and M. canettii (21, (59, 60). Samples 
obtained as Illumina sequencing reads were assembled de novo as previously described (61). 
Samples from M. tuberculosis lineages 1-6 were obtained as PacBio sequencing reads and 
assembled using SMRT v2.2.0 (https://github.com/sanger-pathogens). A summary of the 
samples used in pangenome reconstruction for each species is provided in Supplementary 
Table 3. 
All sample assemblies were annotated using the run_prokka function in Panaroo version 1.2.2 
(15). This function annotates each sample using Prokka(62) with the same gene model for 
each sample. We ran the run_prokka function on each species independently. Samples that 
were outliers based on their number of genes and contigs were removed, as inferred using 
the panaroo-qc scripts (https://github.com/gtonkinhill/panaroo). Pangenomes were 
reconstructed for each species independently using Panaroo v1.2.2 (15) with clean-mode set 
to moderate. 
Clades of interest were DCC1, DCC2 and DCC3 in M. abscessus, cluster Ia in M. avium, the 
M. tuberculosis complex and clone 1A in M. canettii. Genes that were gained or lost leading 
to a clade were identified through phylogenetic reconstruction. We mapped samples from 
each species or subspecies against their corresponding reference genome (ATCC 19977 for 
M. a. abscessus, CIP_108297 for M. a. massiliense, TH135 for M. avium, H37Rv for M. 
tuberculosis and M. canettii) using the multiple_mappings_to_bam pipeline 
(https://github.com/sanger-pathogens/bact-gen-scripts) with BWA-MEM as the aligner. A 
phylogenetic tree was reconstructed on the variable positions for each alignment using RAxML 
version 8.2.9 (63) with the GTR model of nucleotide substitution and gamma rate 
heterogeneity with four gamma classes. Each accessory gene was reconstructed onto the 
respective phylogenetic tree using PastML (64). Genes gained leading to a clade of interest 
were included if they were present in ≥70% of samples in the clade and ≤30% of remaining 
samples in the species. Genes lost leading to a clade of interest were included if they were 
present in ≤30% of samples from the clade and ≥70% of remaining samples in the species. 
 12 
The lists of genes identified can be found in Supplementary Tables 1 and 4. To supplement 
our analysis of M. abscessus DCCs, any gene gain or loss events annotated as “hypothetical” 
underwent further functional analysis: MetaCyc (65), which is a non-redundant database of 
metabolic pathways, enzymes and reactions, was interrogated. Distantly related homologs 
were identified using simultaneous BLAST(66) and HMMER(67) searches were done using 
the following databases: PFAM(68), SCOP(69), NCBI(70), Uniprot(71), ESTHER(72) and on 
the Transporter Classification Database(73). 
For illustration purposes the pangenome graphs were simplified so that they were ordered 
against an appropriate reference genome, and any long-range edges were cut. Briefly, pairs 
of genes that were more than 100 genes apart in the reference genome and had a path 
connecting the two genes using only non-reference genes in the graph were identified. For 
each long-range connection, a minimal set of edges was identified and removed from the 
graph to cut that path. This was performed iteratively until there were no more long-range 
edges (34).  
The final graphs were visualised using Cytoscape v3.7.1 (74), and arranged using the organic 
graph layout from the yFiles plugin. 
Structural model of DpnM 
The homology model for M. abscessus DpnM was built using the SAM-bound DNA adenine 
methyltransferase from Streptococcus pneumoniae as template (PDB ID: 2DPM(75), percent 
identity of 35% and similarity of 66%) using Modeller (v9.21)(76). The best model was selected 
using the DOPE (Discrete Optimised Potential Energy) score(77). The residue of interest 
(F42) was mapped onto the SAM bound modelled structure using UCSF Chimera(78). The 
model for the mutant F42S was obtained using the swapaa command in Chimera. DNA-bound 
form was modelled using the E. coli DNA adenyl methyltransferase structure (PDB ID: 2G1P). 
Construction of dpnM knockout strain and complementation 
A representative of DCC3 (BIR1049, accession GCF_900137475.1) was chosen as a strain 
for knockout construction. Deletion of the inserted mobile element in BIR1049 was carried out 
using a modified protocol of mutagenesis by recombineering for M. abscessus(79). Briefly, 
primers were designed to amplify 1000bp flanking regions upstream and downstream of the 
mobile element containing dpnM. A streptomycin cassette (obtained from pHP45W) was 
cloned between the upstream and downstream fragments of the target gene to create an allelic 
exchange substrate (AES). A modified version of pJV53 containing the xylE gene (pJV53-
xylE) was used to create a recombineering strain of M. a. massiliense isolate BIR1049 
(BIR1049-pJV53-xylE). BIR1049-pJV53-xylE was grown to OD=0.5, induced for 4h with 0.2% 
acetamide and electroporated with the AES. Transformants were plated on 7H11 agar 
supplemented with ADC containing selective antibiotic (200 μg/mL streptomycin). Clones 
were selected and checked for the AES by PCR. In order to remove pJV53-xylE, selected 
clones were grown in liquid broth under streptomycin selection only for two weeks, plated and 
checked by 1% catechol to confirm they lost the pJV53-xylE plasmid. Thereafter, mutant 
colonies are kanamycin-sensitive streptomycin-resistant. 
To generate a complementation of dpnM the gene was PCR amplified, digested with EcoRI 
and HindIII and ligated to pMV306H-hsp60 cut with the same enzymes. The plasmid was 
electroporated into BIR1049DdpnM and transformants were selected on 7H11 ADC plates 
with Hygromycin 1mg/ml and confirmed by PCR. 
BIR1049DdpnM and complementation strains were validated by whole genome sequencing.  
SMRT sequencing of BIR1049DdpnM 
BIR1049 and BIR1049DdpnM were grown for in 10 mL of 7H9 broth supplemented with ADC 
and glycerol at 37oC. Culture tubes were spun in a centrifuge at 1,900 xg for 5 minutes and 
the pellet was resuspended in 250 μL TE buffer. The suspension was transferred into a tube 
containing 500 μL of 0.1 mm silica beads and subjected to three 30-second pulses with 30 
seconds rest between pulses using a mini bead beater (BioSpec, USA). DNA extraction was 
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performed using the QIAmp DNA mini kit (QIAGEN, UK) and elution performed using 100 μL 
of MilliQ water.  
The Pacific Biosciences RSII instrument was used to perform SMRT sequencing on eight 
isolates at the Wellcome Trust Sanger Institute (accession ERP010248). One SMRT-cell was 
used per isolate. Post sequencing analysis was performed using the SMRT-analysis.2.3.0 
pipeline available via the SMRT-portal. The sequencing reads were assembled using HGAP 
v3(80). This involves three steps. Firstly, pre-assembly which aims to produce long and 
accurate sequences. This is followed by the assembly of these high quality sequences into a 
draft genome (GCF_900137475.1) and finally, the correction of the draft assembly by the 
PacBio RS_Resequencing protocol and Quiver (v1). The approximate genome size parameter 
was set to 5Mbp (approximately the size of the M. a. abscessus genome) and the target 
coverage was set to 25. RS_Modification_and_Motif_Analysis.1 was run using the SMRT 
analysis software v2.3.0 embedded in the SMRT-portal. Briefly, this protocol uses SFilter to 
remove short reads and sequencing adapters. The filtered reads are then mapped to the 
assembly produced by HGAP using BlasR v1(81). Kinetic analysis is then applied to the 
alignment of the reads to the reference enabling the identification of the modified bases by 
detecting bases where the interpulse duration ratio (IPDR) was significantly different from that 
of the in silico control(82). The modified motifs recognized by the methylases present in the 
genome were then identified using Motif Finder v1, with a minimum modification quality 
(MODQV) threshold of 30.  
RNA extraction  
Mycobacterial RNA was extracted from BIR1049 and BIR1049DdpnM using a combination of 
bead beating and RNAeasy mini kit (QIAGEN, UK). Bacterial cultures were grown in DifcoTM 
Middlebrook 7H9 broth supplemented with ADC, Tween 80, and glycerol until culture 
saturation at 37°C with 100 xg. One hundred microliters of saturated cultures were used to 
inoculate 10 ml of 7H9 broth supplemented with ADC and glycerol and cultures were grown 
at 37°C with 100 xg until mid-logarithmic stage. Culture tubes were spun in a centrifuge at 
1,900 xg for 10 minutes and the pellet stored immediately at -80oC until extraction. At the time 
of extraction, the pellets were removed from -80oC and placed in ice. The frozen pellets were 
resuspended in 700 μL of RLT buffer containing 1% β-mercaptoethanol, and transferred to a 
tube containing 500 μL of 0.1 mm silica beads and subjected to two 2-minute pulses with 1 
minute rest in between using a mini bead beater (BioSpec, USA). Samples were spun in a 
centrifuge for 2 minutes at 7,200 xg and 700 μL of the supernatant were transferred into a 
gDNA eliminator column. Additional 500 μL of RLT buffer containing 1% β-mercaptoethanol 
were added, the samples spun in a centrifuge at 7,200 xg and 300 μL of the supernatant were 
added to the same gDNA eliminator column. The columns were spun in a centrifuge at 8,600 
xg for 1 minute and the flow-through collected. One volume of 70% ethanol was added to the 
flow-through, transferred onto a RNA mini column, and spun in a centrifuge at 8,600 xg for 1 
minute, discarding the flow-through. The columns were then washed with 700 μL of RW1 
buffer, followed by two washes with 500 μL of RPE buffer. RNA was eluted using 30 μL of 
RNase-free water.  
RNAseq of BIR1049DdpnM 
RNAseq was performed on BIR1049 and BIR1049DdpnM at the Wellcome Trust Sanger 
Institute using the Illumina HiSeq 2500 platform (accession ERP016362). Gene expression 
values were computed from the read alignments to the coding sequencing to generate the 
number of reads mapping and reads per kilobase per million (RPKM). Only reads with a 
mapping quality score of 10 were included in the count. Genes differentially expressed in the 
presence and absence of the methyltransferase were determined using DESeq2 (v.1.20)(83). 
P-values were corrected for multiple testing using the Benjamini Hochberg method. 
Significantly differentially expressed genes were identified as those with a log2 fold change 
greater than 2 or less than -2 with a corrected p-value less than 0.05. Experiments were 
performed in triplicate biological replicates for each condition. 
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Inference of subclonal population structure (Minority Variant-trees) 
Whole genome sequencing (as described above) was carried out on longitudinal plate sweep 
samples (Figure 5A).  Reads were mapped to the appropriate subspecies reference genome 
(M. a.. abscessus (NC_010394.1)(35), M. a. massiliense or M. a. bolletii de novo assemblies 
as described previously (84)) using SMALT (85). Samples with less than 20x average read 
depth, or an excess of heterozygous positions (indicating contamination) were excluded from 
analysis.   
Consensus variants that passed stringent quality filters were called as described previously 
(8), and variable positions between same-patient isolates identified. In order to detect minority 
variants (Figure 5B), where all reads do not agree on a consensus sequence, stringent filters 
were applied.  As a first step, stringent mapping was used where in addition to the default 
SMALT (85) parameters, a minimum nucleotide identity of 0.98 was applied, which avoided 
the mapping of reads with more than one mis-match which could be considered poor quality. 
To distinguish sequencing errors from true variants, a minority variant had to be supported by 
at least 5 reads, where at least 2 reads were mapped to each strand, and a strand bias P-
value cutoff of 0.05 (calculated by bcftools(37)) was applied. To avoid heterozygous positions 
which may arise due to mis-mapping, the base positions had to have a depth of coverage 
within a normal range (+/- 50% of the average). The alternative (non-reference) allele 
frequency for the all within-patient variant positions was extracted. 
We noticed that many variants followed the same allele frequency trajectory (Figure 5C), 
suggesting that they formed the same haplotype or subclone (Figure 5D). We developed MV-
trees (https://github.com/JosieMB/MV_trees.git) to exploit these patterns to infer the 
underlying subclonal population structure. In order to identify variants which had the same 
allele frequency trajectory over time, density-based clustering was performed using DBSCAN 
(86) in R (version 3.4.2) using allele frequency as input and minPts as 2. The eps value was 
selected by generating a k-nearest neighbor distance plot (kNNdistplot function) with k as 2.  
Variants whose allele frequency trajectory clustered into the same group were considered a 
single subclone. Variants that could not be clustered (referred to as “noise” by the algorithm) 
were considered singleton variant subclones. Subclonal frequencies could then be tracked 
over time using the mean allele frequency of the assigned variants for each time point (Figure 
5D). 
Quality filtering was performed to remove clusters where over 20% of the variants were within 
a read length (150 nucleotides) of one another, indicating variation due to mis-mapping or 
recombination. Similarly, singleton variants that were located within 150 nucleotides of other 
singleton variants were also removed. 
The resultant allele frequency trajectories can be used to infer ancestral relationships between 
the subclones. For example, if mean allele frequency trajectory of subclone A follows a similar 
path to subclone B but is sometimes higher, then subclone A is the ancestor to B. However if 
subclones have allele frequency trajectories that are dissimilar, then they are considered 
unlinked and don’t have an ancestor-descendent relationship.  
The ancestor-descendent relationships between the subclones were inferred in a pairwise 
fashion (here referred to as subclone A and subclone B) if the following requirements were 
satisfied (allowing ±0.05 to allow random deviation due to variation in sequencing depth): 
for all time points the mean AF (allele frequency) of subclone A ³  subclone B 
atleast once the mean AF of subclone A > subclone B 
atleast once the mean AF of subclone A + subclone B > 1 
If all three conditions are not met but that the mean AF of subclone A + subclone B is always 
£ 1 then they are considered sister taxa (unlinked). 
If, atleast once, the mean AF of subclone A + subclone B > 1 but that at different time points 
subclone A < subclone B or subclone A> subclone B then this relationship is considered 
evolutionary incompatible. This means subclone A or B is problematic which could be caused 
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by homoplasy or recombination. In order to identify problematic clones or singleton variants, 
the node with the most number of problematic relationships is removed and the ancestor-
descendent relationship inference is re-run. This is repeated iteratively until no more 
problematic relationships remain.  
This process infers all ancestor-descendent relationships which then need to be reduced down 
to direct parent-child relationships. Assuming that the evolutionary relationships can be 
represented by a single tree structure (acyclic directed graph) this is achieved through 
transitive reduction (Figure 5E) as implemented in the ‘nem’ R package (87). The resultant 
tree is drawn using igraph (88). We found that common drug resistance mutations were often 
filtered from the analysis due to being homoplasious and associated with multiple clones. In 
order to include these variants their likely position on the tree was assessed manually using 
the AF data and added to the final trees.  
Validation of subclonal relationship inference 
In order to validate the inferred subclonal trees generated from sweep data, we whole genome 
sequenced single colony purified samples from the same collection. Three samples were 
selected from three patients, where the sample was predicted to contain multiple subclones 
from the sweep data. Thirty single colonies were randomly picked from each for whole genome 
sequencing (as previously). Consensus variants were called as previously, and a maximum 
likelihood phylogenetic tree (RAxML) was constructed for each patient. The resultant tree was 
compared with the subclonal tree inferred from the sweep data. In two of the cases the 
maximum-likelihood tree formed a subtree of the total subclonal tree with identical internal tree 
structure (Supplementary Figure 4). Additional variants were identified on the tips of the 
single-colony trees not identified in the subclonal tree, which were unique to single colonies 
so occurred at a low frequency and were filtered from the analysis. In patient 6 an additional 
drug resistance mutation was identified as an internal node which was likely excluded from 
the sweep analysis as it occurred at the same position as another drug resistance mutation. 
Currently the method assumes variants are biallelic.  
Sputum repertoire and community analysis 
Sputum samples from the same patient with similar subclonal composition were clustered by 
subclonal repertoire using DBSCAN(86) in R (version 3.4.2), using frequency of subclone as 
input.  
Community analysis was used to determine if the inferred subclones co-occurred with other 
subclones in a non-random fashion. This was achieved by constructing networks based on 
frequency of co-occurrence between subclones. The number of times subclones co-occurred 
in the same sputum was counted and then corrected for overall prevalence of the subclone. 
Pairwise frequencies of co-occurrence between each subclone in a patient was then used to 
create an undirected weighted graph implemented by “graph.adjacency” in the igraph package 
(version 1.2.4.1)(89). Hypothetical communities were identified as nodes that were densely 
connected to themselves but sparsely connected to others, as implemented by the 
“edge.betweenness.community” function in the igraph package(89).  
Intra- and inter- patient parallel evolution 
Genes were identified as having evidence of intra-host parallel evolution when they 
accumulated more than one non-synonymous variant on independent branches on the 
inferred subclonal trees. Genes with inter-patient parallel evolution were those that acquired 
non-synonymous variants in multiple patients at a rate higher than considered by chance using 
a ‘burden of mutation’ approach(90). This method estimates the ρSN (synonymous mutation 
rate) by dividing the observed number of synonymous SNPs by the number of coding 
sequence bases in the reference genome. The expected nonsynonymous mutation rate (ρNS) 
is then estimated using the following equation: ρNS = ρSN X R. R represents the ratio of 
nonsynonymous sites to synonymous sites and is determined by permuting every base of 
every codon in silico and identifying whether it resulted in a synonymous or nonsynonymous 
change. This was done on a per gene level, with the number of synonymous SNPs 
 16 
accumulated per gene used to estimate the value of ρSN per site per gene. If no synonymous 
SNPs were observed in a gene the synonymous mutation rate estimated for the whole genome 
was used. Finally, to obtain the expected number of nonsynonymous SNPs per gene, ρNS 
was multiplied by the gene length.  
To determine if the observed number of nonsynonymous SNPs was significantly greater than 
the expected, a one tailed binomial test was used. The p-values were corrected for multiple 
testing using Benjamini Hochberg method, and we applied a significance threshold of 0.01.  
STRING-based analysis of protein-protein interactions.  
M. abscessus proteins that were frequently mutated within patients were mapped to their M. 
tuberculosis orthologues using the SYNERGY orthogroup resource [91]. The STRING 
database (v11.0) was queried with those genes with clear orthologues to infer a protein 
network based on protein-protein interactions allowing up to 30 additional proteins directly 
interacting with the input set of proteins requiring a minimum confidence of 0.4 [92]. 
Measurement of mutation transmissibility 
Mutations were identified across the global collection of M. abscessus isolates [9] that 
occurred in genes of interest:  
• Frameshift and nonsense mutations in the GPL loci MAB_4098 and MAB_4099) 
• Nonsynonymous mutations in phoR (sensor loop and non sensor loop region as 
described in figure 3F) 
• Known antibiotic resistance mutations in 23s rRNA for macrolides (A2058 A2059) and 
aminoglycosides (A1408 C1409). 
Mutations on the deep branches leading to the three subspecies were excluded. Mutations 
were considered transmitted (shared by more than one patient in a monophyletic clade) or 
non-transmitted (unique to one patient). The statistical significance of the observed differences 
in transmissibility was calculated through comparison to all mutations using a Fishers exact 
test. 
Construction of M. abscessus knockout and complemented strains. 
DdpnM: A representative of DCC3 (BIR1049, accession GCF_900137475.1) was chosen as 
a strain for knockout construction. Deletion of the inserted mobile element in BIR1049 was 
carried out using a modified protocol of mutagenesis by recombineering for M. abscessus [93]. 
Briefly, primers were designed to amplify 1000bp flanking regions upstream and downstream 
of the mobile element containing dpnM. A streptomycin cassette (obtained from pHP45W) was 
cloned between the upstream and downstream fragments of the target gene to create an allelic 
exchange substrate (AES). A modified version of pJV53 containing the xylE gene (pJV53-
xylE) was used to create a recombineering strain of M. a. massiliense isolate BIR1049 
(BIR1049-pJV53-xylE). BIR1049-pJV53-xylE was grown to OD = 0.5, induced for 4h with 0.2% 
acetamide and electroporated with the AES. Transformants were plated on 7H11 agar 
supplemented with ADC containing selective antibiotic (200 μg/mL streptomycin). Clones 
were selected and checked for the AES by PCR. In order to remove pJV53-xylE, selected 
clones were grown in liquid broth under streptomycin selection only for two weeks, plated and 
checked by 1% catechol to confirm loss of the pJV53-xylE plasmid. Mutant colonies were this 
characterised as kanamycin-sensitive and streptomycin-resistant. To generate a 
complementation of dpnM the gene was PCR amplified, digested with EcoRI and HindIII and 
ligated to pMV306H-hsp60 cut with the same enzymes. The plasmid was electroporated into 
BIR1049DdpnM and transformants were selected on 7H11 ADC plates with Hygromycin 
1mg/ml and confirmed by PCR. BIR1049DdpnM and complementation strains were validated 
by whole genome sequencing.  
DphoPR: A knockout strain of the phoPR locus was generated in M. a massiliense CIP108297, 
using the same method as described above for dpnM. For complementation of phoPR, the 
operon plus a 130bp upstream region containing the promoter was PCR amplified from M. 
massiliense CIP108297 or from clinical strains containing mutations in PhoR, digested with 
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XbaI and HindIII and ligated to pMV306-xylE cut with the same enzymes. The construct was 
then electroporated into CIP108297DphoPR and transformants were selected in 7H11 ADC 
plates with Kanamycin 200µg/ml and confirmed by PCR. 
CRISPR interference (CRISPRi) using dCas9 in M. abscessus 
We optimised a previously described tetracycline inducible CRISPr Interference system [94] 
for M. abscessus ATCC19977 utilizing a dCas9 encoding plasmid (pTetInt-dcas9-Hyg) and a 
second vector (pGRNAz) containing a custom designed small-guide RNA (sgRNA) cassette. 
The dCas9-expressing strains were cultivated in Middlebrook 7H9 broth supplemented with 1 
× ADC, 0.05% Tween-80 and 0.8% glycerol, hygromycin 1 mg/mL, Zeocin 300 µg/mL. 
Induction of gene silencing was achieved by adding anhydrotetracycline (ATc) 100 ng/mL. 
Three 20 nucleotide guides were designed per gene of interest and annealed and cloned 
between sphI and aclI of the pGRNAz. The dCas9-expressing strains were then transformed 
with the sgRNA encoding vectors.  
SMRT sequencing of BIR1049 WT and DdpnM 
BIR1049 and BIR1049DdpnM were grown for in 10 mL of 7H9 broth supplemented with ADC 
and glycerol at 37 oC. Culture tubes were spun in a centrifuge at 1,900 x g for 5 minutes, the 
pellet resuspended in 250 μL TE buffer, and then transferred into a tube containing 500 μL of 
0.1 mm silica beads and subjected to three 30-second pulses with 30 seconds rest between 
pulses using a mini bead beater (BioSpec, USA). DNA extraction was performed using the 
QIAmp DNA mini kit (QIAGEN, UK) and elution performed using 100 μL of MilliQ water.  
SMRT sequencing on eight isolates was performed at the Wellcome Sanger Institute (using a 
Pacific Biosciences RSII instrument). One SMRT-cell was used per isolate. Post sequencing 
analysis was performed using the SMRT-analysis.2.3.0 pipeline available via the SMRT-
portal. The sequencing reads were assembled using HGAP v3 [95]. This involves three steps. 
Firstly, pre-assembly which aims to produce long and accurate sequences. This is followed 
by the assembly of these high-quality sequences into a draft genome (GCF_900137475.1) 
and finally, the correction of the draft assembly by the PacBio RS_Resequencing protocol and 
Quiver (v1). The approximate genome size parameter was set to 5Mbp (approximately the 
size of the M. a. abscessus genome) and the target coverage was set to 25. 
RS_Modification_and_Motif_Analysis.1 was run using the SMRT analysis software v2.3.0 
embedded in the SMRT-portal. Briefly, this protocol uses SFilter to remove short reads and 
sequencing adapters. The filtered reads are then mapped to the assembly produced by HGAP 
using BlasR v1 [96]. Kinetic analysis is then applied to the alignment of the reads to the 
reference enabling the identification of the modified bases by detecting bases where the 
interpulse duration ratio (IPDR) was significantly different from that of the in silico control [97] 
The modified motifs recognized by the methylases present in the genome were then identified 
using Motif Finder v1, with a minimum modification quality (MODQV) threshold of 30.  
RNAseq of BIR1049 WT and DdpnM 
RNA extraction: Mycobacterial RNA was extracted from BIR1049 and BIR1049DdpnM using 
a combination of bead beating and RNAeasy mini kit (QIAGEN, UK). Bacterial cultures were 
grown in DifcoTM Middlebrook 7H9 broth supplemented with ADC, Tween 80, and glycerol 
until culture saturation at 37 °C with 100 x g. One hundred microliters of saturated cultures 
were used to inoculate 10 ml of 7H9 broth supplemented with ADC and glycerol and cultures 
were grown at 37 °C with 100 x g until mid-logarithmic stage. Culture tubes were spun in a 
centrifuge at 1,900 x g for 10 minutes and the pellet stored immediately at -80 oC until 
extraction. At the time of extraction, the pellets were removed from -80 oC and placed in ice. 
The frozen pellets were resuspended in 700 μL of RLT buffer containing 1% β-
mercaptoethanol, and transferred to a tube containing 500 μL of 0.1 mm silica beads and 
subjected to two 2-minute pulses with 1 minute rest in between using a mini bead beater 
(BioSpec, USA). Samples were spun in a centrifuge for 2 minutes at 7,200 x g and 700 μL of 
the supernatant were transferred into a gDNA eliminator column. Additional 500 μL of RLT 
buffer containing 1% β-mercaptoethanol were added, the samples spun in a centrifuge at 
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7,200 x g and 300 μL of the supernatant were added to the same gDNA eliminator column. 
The columns were spun in a centrifuge at 8,600 x g for 1 minute and the flow-through collected. 
One volume of 70% ethanol was added to the flow-through, transferred onto a RNA mini 
column, and spun in a centrifuge at 8,600 x g for 1 minute, discarding the flow-through. The 
columns were then washed with 700 μL of RW1 buffer, followed by two washes with 500 μL 
of RPE buffer. RNA was eluted using 30 μL of RNase-free water.  
RNAseq: RNAseq was performed on BIR1049 and BIR1049DdpnM at the Wellcome Trust 
Sanger Institute using the Illumina HiSeq 2500 platform on at least three biological replicates 
per condition. Gene expression values were computed from the read alignments to the coding 
sequencing to generate the number of reads mapping and reads per kilobase per million 
(RPKM). Only reads with a mapping quality score of 10 were included in the count. Genes 
differentially expressed in the presence and absence of the methyltransferase were 
determined using DESeq2 (v.1.20) [98]. P-values were corrected for multiple testing using the 
Benjamini-Hochberg method. Significantly differentially expressed genes were identified as 
those with a log2 fold change greater than 2 or less than -2 with a corrected p-value less than 
0.05.  
Mouse infection experiments.  
Specific-pathogen-free βENaC transgenic mice, were purchased from the Jackson 
Laboratories, Bar Harbor, ME (Stock No: 006438-B6.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc/J). 
Mice were rederived and maintained at Colorado State University (CSU) and were given 
sterile water, mouse chow and enrichment for the course of experiment. All experimental 
protocols were approved by the Animal Care and Use Committee of Colorado State University 
(Approvals: IRB #14-032B, IACUC#1020). Mycobacteria were grown at 30 °C in Middlebrook 
7H9 broth supplemented with 10% (v/v) oleic acid/albumin/dextrose/catalase (OADC) 
enrichment and 0.05% Tween 80 or on 7H10 agar containing 10% (vol/vol) OADC with 
appropriate antibiotics. 
Experimental infections: Mice (6 weeks old, females) were challenged with wild type (WT) M. 
abscessus, phoPR knockout mutant (PhoPRΔ), PhoPRΔ::PhoPRwt (blue) or 
PhoPRΔ::PhoPRmut. using an intratracheal infection calibrated to deliver 1 x 109 bacilli per 
animal. At days 1, 10, and 20 following infection, bacterial loads in the lungs, spleen, and liver 
were determined and lung histology examined. Bacterial counts were determined by plating 
serial dilutions of whole organ homogenates on 7H11-OADC agar and counting colony-
forming units after 5-10 days incubation at 30 oC. At least five animals were infected for each 
condition at each time point with data presented as the mean ± s.e. using Student t-test to 
determine statistical significance. For histological analysis, the whole lung from each mouse 
was fixed with 10% formalin in phosphate buffered saline (PBS). Tissue sections were stained 
using haematoxylin and eosin and acid-fast stain as previously reported [9].  
Colorado State University’s (CSU) animal care program follows the recommendations of the 
NRC Guide for the Care and Use of Laboratory Animals (National Research Council, 2010), 
the requirements of the Public Health Service (PHS) Grants Administration Manual, and The 
Animal Welfare Act as amended. CSU files assurances with the DHHS Office of Extramural 
Research, Office of Laboratory Animal Welfare (OLAW), the Public Health Service, and 
adheres to NIH standards and practices for grantees. CSU’s Animal Welfare Assurance 
Number is A3572-01. CSU animal research facilities have been accredited by the Association 
for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). All care 
and use of animals is overseen by the Institutional Animal Care and Use Committee (IACUC). 
The CSU Laboratory Animal Resources has a fully trained staff that includes multiple 
laboratory animal staff veterinarians as well as an AAALAC accredited Laboratory Animal 
Veterinarian residency training program that currently has multiple trainees in various stages 




Primary Macrophage and THP1 cell infection assays with M. abscessus.  
Primary human macrophages were generated from peripheral blood samples from consented 
healthy volunteers (males and females aged 24-54) as previously described [99] under 
Regional ethics approval REC 12/WA/0148. 
Briefly, Peripheral Blood Mononuclear Cells (PBMCs) were isolated from citrated samples by 
density gradient separation (Lympholyte; Cedarlane Labs), and subjected to CD14+ positive 
selection (MACS Miltenyi Biotec). CD14+ cells were counted, added to 24 well sterile tissue 
culture plates at 0.2 x 106 cells / well, and then differentiated in  macrophages with either (i) 
recombinant human macrophage colony-stimulating factor (M-CSF; 200 ng/ml) or (ii) 
granulocyte-macrophage colony-stimulating factor (GM-CSF; 200 ng/ml) followed by 
interferon-g (IFN-g; 50 ng/ml) during culture in DMEM media containing 10 % fetal calf serum, 
100 U/ml penicillin, and  100 µg/ml streptomycin (Sigma), with antibiotics removed before 
infection experiments. Cells were maintained at 37oC 5% CO2 
At Day 7, macrophages were washed twice with sterile phosphate buffered saline (PBS), 
incubated with M. abscessus at an MOI of 3:1 (for phoPR experiments) or 5:1 (for dpnM and 
CRISPRi experiments) for 2h (in culture media), washed twice in PBS, and then incubated for 
indicated times in culture media. Viable intracellular M. abscessus was assessed at specified 
time points by washing macrophages twice with sterile PBS and then lysing the cells (in sterile 
water) and plating on 7H11 or Columbia Blood Agar plates to enumerate colony forming units 
(as previously [9]).  
THP1 cells (obtained directly from ATCC; ATCC-TIB-202) were differentiated using 12ng/ml 
PMA (Sigma) as previously [1], infected for 2 hours with M. abscessus at specified MOIs, and 
then washed and incubated and treated as above. 
All experiments were performed at least in triplicate biological replicates on at least three 
separate occasions and data represented as the mean ± s.e with statistical significance 
determined using Student t-test. 
Fomite experiments.  
Cultures were grown in 7H9+ADC liquid media, centrifuged, resuspended in sterile PBS, and 
colony forming units determined by serial dilution on 7H11 agar plates (to give the input 
bacterial number. 20 µl of culture was added to sterile glass cover slips in wells of a sterile 24 
well tissue culture plate, which were air dried, and stored in the open in a CL2 microbiological 
safety cabinet.  At 24h, 48h, 7 days and 14 days, 100µl of sterile PBS was added to the cover 
slips in the well and incubated for 10 minutes at RT. The PBS was mixed in the well by pipetting 
and then plated in serial dilution onto 7H11 plates and colony forming units measured after 
incubation at 37oC 5% CO2.  
All experiments were performed at least in triplicate biological replicates on at least three 
separate occasions and data represented as the mean ± s.e with statistical significance 
determined using Student t-test. 
Resistance to amikacin of M. abscessus BIR1049 WT and DdpnM strains was determined 
by MIC determination using broth microdilution (in 7H9 + ADC liquid media) according to CLSI 
standard protocols (Clinical and Laboratory Standards Institute M07 11th edition; clsi.org). 
All experiments were performed at least in triplicate biological replicates on at least three 
separate occasions. 
Mycobacterial resistance to nitric oxide.  
To evaluate resistance to nitric oxide, we exposed M. abscessus to a NO-producing solution 
of sodium nitrite and citric acid [70]. M. abscessus BIR1049 WT and DdpnM (grown in liquid 
culture) were resuspended in 7H9 with ADC in 100 µl aliquots. Sodium Nitrite (at final 
concentrations as indicated in Figure 1F) and citric acid (at final concentration of 0.1M) were 
added to the aliquots which were then mixed by gentle inversion, and incubated for 24 hours 
at 37 oC. Samples were then plated onto Columbia Blood Agar plates and colony forming units 
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enumerated at Day 5. Experiments were performed in at least triplicate biological replicates 
and on three separate occasions (with representative experiment shown in Figure 1F). 
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Figure 1. Saltational evolution of M. abscessus dominant circulating clones. 
(A) Pangenome graph of M. abscessus (constructed using Panaroo [15]), where nodes 
represent clusters of orthologous genes and two nodes are connected by an edge if they are 
adjacent on a contig in any sample from the population, defines gene gain events associated 
with the emergence of DCC1 (purple), DCC2 (blue), and DCC3 (orange).  For illustration 
purposes, the graph has been ordered against M. abscessus ATCC19997, and any long-
range edges cut [34]. (B) Pangenome analysis of the three dominant circulating clones of M. 
abscessus (DCC1-3) revealed horizontal acquisition of potential virulence genes (complete 
gene list in Supplementary Table 1). All DCCs have independently acquired genes involved 
in DNA modification including a putative DNA methylase (DpnM) found in DCC3 (modelled 
structure shown: DPPY motif red; F42 green; bound DNA blue; predicted DNA-recognition 
residues magenta). (C) Genome-wide differential methylation (detected by SMRT sequencing; 
red) and transcription (monitored through RNAseq; global blue, significant differences purple) 
between wild type (WT) and DpnM knockout (DpnMD) M. abscessus, with predicted 
methylation motif shown as weblogo below. (D) Volcano plot of differentially expressed genes 
(log2 fold change greater than 2 or less than -2 with a corrected p-value less than 0.05) 
between WT and DDpnM M. abscessus, annotated by predicted function. (E) Survival in 
primary human macrophages was impaired in DpnMD (red) compared to wild type (blue), 
complemented by expression of wild type DpnM (green) but not DpnM mutant unable to bind 
substrate (black). All experiments were performed at least in triplicate on at least three 
separate occasions and data represented as the mean ± s.e with statistical significance 
determined using Student t-test. (F, G) DpnMD bacteria (red) are more susceptible to acidified 
nitrite (F) and amikacin (G) than wild type controls (blue). Experiments were performed in 
triplicate on at least three separate occasions. Results from representative experiements 
shown as mean ± s.e with statistical significance determined using two-tailed Student t-test (* 
p < 0.05, ** p <0.01. *** p < 0.001).  
Figure 2. Within-host allopatric evolution of M. abscessus. (A-D)  
M. abscessus subclone evolution during chronic infection, shown for one representative 
individual (P6), illustrating (for a subset of mutations) (A) changes in allele (top) and haplotype 
(bottom) frequencies over time, (B) inferred ancestor-descendent relationship between related 
pairs of haplotypes (top), pruned through transitive reduction to provide direct evolutionary 
relationships (bottom), and (C) resultant phylogenetic reconstruction. (D) Fishplot [33] 
visualisation of the evolution of all inferred subclones from P6 over time. (E) Relationship 
(pairwise comparisons) of subclone repertoire within (alpha diversity) and between (beta 
diversity) sputum samples from 18 patients chronically infected with M. abscessus. (F) 
Detection of communities of subclones (based on co-occurrence frequency analysis) in 18 CF 
patients chronically infected with M. abscessus, including with UNG and Nth hypermutator 
clones (red boxes). Edge thickness represents co-occurrence frequency within (black) and 
between (red) communities. (G) Subclone communities of M. abscessus within P6  permitting 
(H) deconvolution of the fishplot (shown in D). Subclones coloured consistently across A-D, 
G, and H.  
Figure 3. Parallel evolution of M. abscessus within and between patients.  
(A) Example of within-host parallel evolution in P4 where several subclones have 
independently acquired a non-synonymous mutation in phoR (red), engA (yellow), and embC 
(pale blue). (B) Within-patient parallel evolution in 18 patients (each patient represented by a 
concentric circle) of 7 genes (chromosomal position relative to reference (ATCC19997) strain 
shown). Size of circles represent the number of non-synonymous SNPs (or any mutation in 
the case of 23S) present in each patient. (C) Manhattan plot identifying genes with more non-
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synonymous mutations than would be expected by chance across 201 patients (size of circle 
indicates the number of patients mutations were identified in used a one tailed binomial test. 
The p-values were corrected for multiple testing using Benjamini Hochberg method, with non-
significant values (>0.01) shown in the shaded grey area. (D) Network analysis (using String) 
suggests that many of the genes undergoing parallel evolution may be functionally related. 
Edge thickness represents strength of evidence for direct interaction. (E) Impact of inducible 
CRISPRi knockdown of selected genes on M. abscessus survival in primary human 
macrophages at 2h (grey) and 24h (black) post infection (24h/2h ratios shown above), 
bacterial viability assessed by colony forming units (CFU). (F) Intracellular survival within 
primary human macrophages (at 2h (grey) and 24h (black) of wild type (WT) M. abscessus, 
PhoPR knockout (PhoPRD) mutants alone, or expressing empty vector (EV), wild type PhoPR 
(PhoPRwt) or PhoPR containing a patient-derived PhoR mutation (PhoPRmut). Experiments 
were performed in at least triplicate on at least three separate occasions. Results from 
representative experiments shown as mean ± s.e with statistical significance determined using 
two-tailed Student t-test (* p < 0.05, ** p <0.01. *** p < 0.001). (G,H) Infection of bENaC-tg 
mice with wild type (WT, black), PhoPRD (white), PhoPRD::PhoPRwt (blue) or 
PhoPRD::PhoPRmut (red) M. abscessus showing (G) bacterial burden in the lungs and (H) 
representative histology (arrows denote granuloma (left) and mycobacteria (right). Statistical 
significance determined using two-tailed Student t-test (* p < 0.05, ** p <0.01. *** p < 0.001). 
Figure 4. Constrained evolution of M. abscessus 
(A) Transmission rates of mutations are compared between all non-unique SNPs (grey), non-
synonymous non-sensor loop mutations in PhoR (pink), mutations conferring aminoglycoside 
or macrolide resistance in 16S and 23S rRNA respectively (green), non-synonymous PhoR 
sensor loop mutations (red), and non-synonymous mutations affecting GPL production (blue). 
Corresponding sizes clades with shared mutations (represented as number of patients per 
outbreak cluster) are also shown (right). (B, C) Phylogenetic tree of isolates from patients 
within transmission chains, showing examples of (B) transmission of adaptive sensor-loop 
SNPs and (C) preferential cross-infection by subclones with un-evolved phoR. (D) Impaired 
survival on fomites of (i) phoR knockout mutants (red) and (ii) rough isolates with GPL 
mutations (blue) compared to isogenic controls (black). Experiments were performed in at 
least triplicate on at least three separate occasions. Results from representative experiments 
shown as mean ± s.e with statistical significance determined using two-tailed Student t-test (* 
p < 0.05, ** p <0.01. *** p < 0.001). 
Figure 5. Method for inferring subclone population structure.  
(A) Bacterial colony sweeps were taken from culture of longitudinal samples for each patient 
and DNA extracted. (B) DNA was deep sequenced and minority variants called (see Methods 
for details). (C, D) We tracked allele frequencies over time and noticed that many variants 
followed the same frequency trajectory, suggesting that they form a haplotype or subclone. 
(E) We then used MV-trees to infer the underlying subclone population structure and 
subsequently pruned the resultant trees, given their acyclic directed graph relationship, using 
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Figure S1. A dN/dS analysis per phylogenetic branch. The calculated dN/dS ratio for each branch 
in the M. abscessus global population phylogeny plotted against the number of synonymous SNPs 
(used as a proxy for time). The branches leading to the last common ancestors of DCC1 (blue), 
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Figure S2. Pangenome analysis (using genome graphs [ref]) identifies gene acquisition (blue) and loss (red) events associated 
with emergence of virulent clones (blue) within M. abscessus (DCC1. DCC2. DCC3), M. avium subsp. hominissuis (Cluster 1a), 
M. canettii (Clone A), and the broader M. tuberculosis complex (monophyletic MTBC). The accessory genome was mapped onto 
the relevant phylogeny (Figure S3) and gene gain and loss events were identified on the phylogenetic branches leading to the 
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Figure S3. Pangenome analysis of (A) M. avium subsp. hominissuis and (B) M. canettii reveals horizontal gene transfer as a common evolutionary 
event associated with the emergence of virulent clones. Maximum likelihood phylogenies (left; scale bar indicates nucleotide substitutions per site) were used 
for phylogenetic mapping of the accessory genome. Pangenome graphs (right) as constructed using Panaroo [15] showed gene gain and loss events 
associated with pathogenic clades (summarized in Figure S2). Genomes used in the analysis are listed in Supplementary Table 3 and full analysis output 
shown in Supplementary Table 4. (A) Pangenome reconstruction of M. avium subsp. hominissuis, highlighting gene gain events (green) in Cluster 1a, a clone 
associated with more progressive lung disease [20]. We identified transcriptional regulators and DNA methyltransferases uniquely associated with this cluster, 
as well as previously reported genes from the mmpL and Type VII secretion system families  [20]. (B) Combined pangenome reconstruction of the M. 
tuberculosis complex (MTBC) and M. canettii. We extracted gene gain/loss events that occurred on the branch leading to “clonal MTBC” - a monophyletic 
clade of MTBC lineages that evolved from a pool of recombinogenic M. canettii-like strains and identified 57 gene gains (red) and one gene loss event 
(Supplementary Table 3). We also extracted gene gain/loss events that occurred on the branch leading to M. canettii Clone A, a virulent cloneresponsible for 
two outbreaks of lymph-node tuberculosis in Djibouti over three years [21], and whose phylogenetic diversity resembles that of a human transmissible 
pathogen. Clone A had acquired 11 genes that were found in <1% of other M. canetti strains, and a further six that were found in <30%. Of these 17 genes, 
we identified seven IS elements or associated cargo with unknown function that were also  enriched (>70%) in clonal MTBC strains. There were very few 
gene loss events identified, however in M. canettii clone A we identified the loss of hsdS.1 a methyltransferase responsible for m6A modification, which is 
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Figure S4. Subclone analysis. (A) Maximum likelihood phylogeny of M. abscessus constructed with one isolate 
per patient. The 18 patients selected for the within patient subclone analysis are shown (clinical metadata 
described in Supplementary Table 5). (B) Experimentaly confirmation of inferred subclones. Individual colonies 
were picked after culture of M. abscessus isolates on solid media, whole genome sequenced, and results com-

























Figure S5. Changes in genetic diversity over time. (A) Changes in gamma diversity over time. 
The gamma diversity (defined as the total number of subclones inferred for a given patient) is 
plotted against the length of infection (time since first mycobacterial sample) for individuals infected 
with hypermutator (red) and non-hypermutator (blue) isolates. Linear regression (black line) 
performed on patients with nonhypermutator isolates. (B) Genetic diversity of inferred subclones 
increases over time. Changes in genetic distance (SNPs) from most recent common ancestor 
(MRCA) for inferred subclones in patients with non-hypermutator (grey) and hypermutator (UNG, 
blue; Nth, red) M. abscessus isolates over time (days from first sample). After excluding patients 
with hypermutator clones, we observed a positive linear relationship between genetic distance and 






















Time since first sample (days)
Patient 14 (Nth mutation)
Patient 13 (UNG mutation)
Time since first sample (days)

































































































































Figure S6. Subclone analysis of infections with hypermutator M. abscessus isolates. (A) Inferred subclone evolutionary 
tree for Patient 13 (Figure 2) whose isolate acquired a deleterious mutation in the Uracil DNA glycosylase gene UNG in one 
subclone (green node and all progeny). (B) Mutation spectra of Patient 13 isolates (green bars) compared to non-hypermutator 
within-patient variants of M. a. abscessus (black bars) showing an excess of C to T and G to A transitions. (C) Inferred subclone 
evolutionary tree for Patients 14a (green lines) and 14b (purple lines; Figure 2) who share (through cross-infection) both a most 
recent common ancestor (MRCA) and a daughter subclone that has acquired a deleterious mutation in the DNA endonuclease III 
gene Nth (yellow node and all progeny). (D) Mutation spectra of Patient 14a and 14b isolates (yellow bars) compared to non-hy-
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Figure S7. Subclone repertoire in sputum samples. (A,B) Clustering of subclone repertoire in 
sputum samples. Sputum samples collected from the same patient with similar subclonal composition 
were clustered based on their subclonal repertoire using DBSCAN in R (version 3.4.2), providing sub-
clone frequency as input. (A) Number of clusters (blue) and proportion of clustered sputum samples 
(red) observed in each patient (number of sputums that belonged to clusters/ total number of sputums). 
(B) Pairwise comparisons of the collection time interval between sputums in the same subclone cluster 
(red) and sputums in different clusters (black). There is no statistically significant difference between 
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Figure S8. Relationship between co-occurrence of subclones within the same sputum sample and genetic 
distance. (A) The observed frequency of co-occurence of closely genetically-related subclones within the same 
sputum sample (black bars) is significantly higher than that expected by chance (1000 permutations, grey bars; 
Kolmogrov Smirnov test P = 0.004). (B) The phylogenetic distance of subclones co-occurring in the same sputum 
sample (black bars) is significantly shorter (Kolmogrov Smirnov test P = 0.01) than that of subclones co-occuring in 
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Figure S9. Adaptive mutations during chronic infection with M. abscessus. (A) Positions of non-synonymous 
mutations in five genes of interest. Domains were predicted using PFAM6 except for phoR (where the domain 
structure was predicted through homology with M. tuberculosis) and ubiA (where the transmembrane helices were 
predicted using Sosui). Significant enrichment of mutation burden in specific domains was assessed using the 
Fishers exact test. Data for 50S binding domains in engA were predicted. The symbols ** and *** indicate p values 
of < 0.001 and <0.01 respectively. (B) Position of non-synonymous mutations on predictied structure of PhoR 
showing that 70% on non-synonymous SNPs that accumulated in parallel in patients were located in the sensor 
















Supplementary Figure 10 
Figure S10. Increased intracellular survival (A) at a range of multiplicities of infection (MOI) of differentiated THP1 cells and (B) 
over extended time periods in primary human macrophages observed for PhoPRΔ knockout M. abscessus (black circles) 
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Figure S11. Example of maintenance of ancestral subclonal within-patient diversity over many years. (A) Inferred 
subclonal phylogeny from Patient 6. Drug resistance mutations that confer macrolide resistance (red) and aminoglycoside 
resistance (black) are annotated where they first appear (macrolide susceptible subclones shown in green, drug resistant in 
yellow. (B) Time-line of the detection of subclones (letter refer to nodes in (A)), defined as average allele frequency >5% of total 
sampled population from each sputum sample. The corresponding macrolide treatment history is also shown. Drug resistant 
clones (orange) are detected within 18 months of starting azithromycin treatment, and outcompete their drug susceptible 
ancestors (green). However, when azithromycin treatment is withdrawn and clarithromycin treatment commenced temporarily, 
the susceptible clone is once again detectable, indicating that it had still been maintained in the lung population over many 
years. 
Supplementary Figure 12
Figure S12. Proposed generalisable model for mycobacterial pathogenic evolution involving: (1) 
horizontal gene acquisition by environmental clones driving saltational evolution, giving rise to the ances-
tors of the dominant circulating clones of M. abscessus; (2) allopatric within-host adaptation during 
chronic infection driving increased intracellular survival within macrophages and inflammatory lung 
damage; (3) constrained evolution while M. abscessus transmission is via environmental intermediaries, 

























Table S1. (separate file) 
Gene gain/loss events in M. abscessus DCCs 
Table S2. (separate file) 
Differentially expressed genes between control and dpnM knockout strains 
Table S3. (separate file) 
Mycobacterial genomes used in graphical pangenome analysis 
Table S4. (separate file) 
Gene gain/loss events in Cluster 1a within , M. avium, Clone A within M. canettii, and MTBC 
within M. canettii-like ancestor. 
Table S5. (separate file) 
Details of longitudinal samples from chronically M. abscessus-infected patients 
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INTRODUCTION 
Nearly all mycobacterial species are free-living environmental saprophytes. A few, such as 
Mycobacterium tuberculosis, have evolved to cause transmissible human infection and 
eventually to become obligate human pathogens. The recent emergence and global spread 
of virulent clones of the environmental nontuberculous mycobacterium M. abscessus has 
provided a unique opportunity to examine the pathogenic evolution of mycobacteria. 
RATIONALE 
M. abscessus, a multidrug-resistant species of nontuberculous mycobacteria (NTM), has 
recently emerged as a major threat to individuals with Cystic Fibrosis (CF) and other chronic 
lung conditions. Infection rates within the CF community are increasing globally, driven in part 
by indirect person-to-person transmission of M. abscessus. 
Currently over 70% of infections in CF patients are caused by genetically clustered (and thus 
transmitted) isolates, of which the majority are from three dominant circulating clones (DCCs) 
that have emerged within the past 50 years and have spread globally. These clustered isolates 
are more virulent when tested in vitro and in vivo and result in worse clinical outcomes, 
suggesting that they are evolving from environmental saprophytes into obligate lung 
pathogens. We reasoned that functional genomic analysis of M. abscessus might identify 
important generalizable steps in this evolutionary trajectory and highlight potential 
interventions to mitigate this process for this and other emergent mycobacterial pathogens.  
RESULTS 
We initially sought to understand how the DCCs may have emerged and found, using 
graphical pangenome analysis, that horizontal gene transfer, particularly of global 
transcriptional regulators, can provide an important mechanism for creating large phenotypic 
variance in environmental M. abscessus isolates, consequently enabling saltational evolution 
towards enhanced human infectivity. Of note, this process may be generalisable across 
mycobacterial species where gene gain/loss events have been associated with the pathogenic 
evolution of virulent clones in several species including: Cluster 1a within Mycobacterium 
avium, Clone A within Mycobacterium canetti, and the monophyletic M. tuberculosis complex 
from an M. canettii-like ancestor.  
We next examined whether ongoing adaptation of infecting M. abscessus clones could further 
promote pathogenicity.  We reconstructed the evolutionary trajectories of individual M. 
abscessus subclones within chronically infected patients identifying convergent allopatric 
evolution within and between individuals as a key driver for pathogenic adaptation. 
Specifically, recurrent mutations within a small set of genes from a single functional network 
are likely to drive enhanced macrophage survival and increased virulence in vivo. 
Importantly we observed reduced transmission fitness for many adaptive mutations and 
demonstrate for two frequently mutated genes (phoR and the GPL locus), that knockouts 
showed impaired survival on fomites suggesting that within-host evolution is constrained while 
transmission requires an environmental intermediary.  
CONCLUSION 
Our results point to a generalisable model for mycobacterial pathogenic evolution. Initially, 
horizontal gene acquisition by environmental clones (particularly of genes with global 
transcriptional effects) drives saltational evolution and increases virulence, giving rise to the 
ancestors of the dominant circulating clones of M. abscessus, and driving the emergence of 
virulent clones in other mycobacterial species.   
Next, within-host adaptation during chronic infection drives increased intracellular survival 
within macrophages and inflammatory lung damage. Pathogenic evolution is however 
constrained while M. abscessus transmission is via environmental intermediaries, since the 
most highly adapted strains lose transmission fitness through reduced fomite survival.  
Ultimately, we predict that opportunities for direct transmission of emergent mycobacteria 
(potentially through increases in population density and/or host susceptibility) will permit 
unconstrained, accelerated evolution into an obligate human pathogen (as occurred in M. 
tuberculosis several thousand years ago).  
Our findings indicate how key interventions, such as early treatment and cross-infection 
control, might restrict existing, and prevent new, emergent pathogens.  
 
FIGURE LEGEND 
Figure 0. Steps involved in mycobacterial pathogenic evolution: (1) Horizontal gene 
acquisition by environmental clones drives saltational evolution, and gives rise to the 
ancestors of the dominant circulating clones of M. abscessus (and virulent clones within other 
mycobacterial species); (2) Allopatric within-host adaptation during chronic infection drives 
increased intracellular survival within macrophages and inflammatory lung damage; (3) 
Evolution is constrained while M. abscessus transmission is via environmental intermediaries 
since the most highly adapted strains lose transmission fitness through reduced fomite 
survival; (4) Opportunities for direct transmission of emergent mycobacteria (potentially 
through increases in population density and/or host susceptibility) permit unconstrained, 
accelerated evolution (as occurred in M. tuberculosis).  
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